Our data demonstrated that a mutation in tyrosine residue 743 (Y743F) weakened the effect of PIGR on downregulating LAMB3 and deactivating the AKT-FOXO3/4 signaling pathway in CRC cells. The gene discussed is LAMB3; the disease is colorectal carcinoma.